Ubs Global Asset Management Americas »

Heron Therapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.7k 2.1k 0.80
2023-06-30 $167k 111k 1.51
2023-03-31 $167k 111k 1.51
2022-12-31 $277k 111k 2.50
2022-09-30 $467k 111k 4.22
2022-06-30 $309k 111k 2.79
2022-03-31 $634k 111k 5.72
2021-12-31 $1.0M 111k 9.13
2021-09-30 $1.0M 98k 10.69
2021-06-30 $1.6M 103k 15.52
2021-03-31 $1.6M 99k 16.21
2020-12-31 $1.4M 94k 14.82
2020-09-30 $1.4M 94k 14.82
2020-06-30 $1.3M 90k 14.71
2020-03-31 $1.1M 91k 11.74
2019-12-31 $2.1M 91k 23.50
2019-09-30 $1.6M 89k 18.50
2019-06-30 $1.2M 66k 18.59
2019-03-31 $1.4M 58k 24.44
2018-12-31 $1.2M 48k 25.94
2018-09-30 $1.3M 40k 31.65
2018-06-30 $1.3M 34k 38.85
2018-03-31 $720k 26k 27.60
2017-12-31 $230k 13k 18.10
2016-09-30 $262k 15k 17.24
2016-06-30 $274k 15k 18.03
2016-03-31 $289k 15k 19.01
2015-12-31 $406k 15k 26.71